These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9014488)

  • 1. Drug education. Moving ahead the fourth year.
    Seibert DJ
    Pa Med; 1997 Jan; 100(1):22-4, 26. PubMed ID: 9014488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pennsylvania takes lead in drug education venture.
    Harley NA
    Pa Med; 1993 Jul; 96(7):12-4. PubMed ID: 8414593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a DUR intervention: a case study of histamine antagonists.
    Zimmerman DR; Collins TM; Lipowski EE; Sainfort F
    Inquiry; 1994; 31(1):89-101. PubMed ID: 7909535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DUR program moving ahead in second year.
    Layne BA; Oravec SL
    Pa Med; 1994 Oct; 97(10):34-5. PubMed ID: 7816471
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of Medicaid prior authorization on angiotensin-receptor blockers: can policy promote rational prescribing?
    Fischer MA; Choudhry NK; Winkelmayer WC
    Health Aff (Millwood); 2007; 26(3):800-7. PubMed ID: 17485759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceuticals: pharmaceutical cost controls--2005. End of Year Issue Brief.
    Seay M; Varma P
    Issue Brief Health Policy Track Serv; 2005 Dec; ():1-20. PubMed ID: 16708455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
    Sneed RC; May WL; Stencel C
    Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determining physicians' knowledge and attitudes when prescribing drugs to treat gastrointestinal disorders.
    Soons KR; Lynch T; Seagrave M; Rolley L
    Clin Perform Qual Health Care; 1997; 5(2):94-8. PubMed ID: 10167220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DUR program moving ahead in fourth year.
    Layne BA
    Pa Med; 1996 Dec; 99(12):24-5. PubMed ID: 8993072
    [No Abstract]   [Full Text] [Related]  

  • 10. Medicaid program; drug use review program and electronic claims management system for outpatient drug claims--HCFA. Final rule.
    Fed Regist; 1994 Sep; 59(184):48811-25. PubMed ID: 10137645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The financial impact of OBRA-90 on community pharmacies: an overview.
    Nightengale B; Reeder CE
    Clin Ther; 1993; 15(3):581-92. PubMed ID: 8364950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicare and Medicaid programs; preadmission screening and annual resident review--HCFA. Final rule with comment period.
    Fed Regist; 1992 Nov; 57(230):56450-514. PubMed ID: 10122884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AHCA (American Health Care Association) leaders look to the year ahead.
    Rogers W; Baldwin B; Willging P
    Provider; 1992 Feb; 18(2):29-31. PubMed ID: 10119634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ambulatory drug utilization review: opportunities for improved prescription drug use.
    Lyles A; Sleath B; Fulda TR; Collins TM
    Am J Manag Care; 2001 Jan; 7(1):75-81; quiz 82-3. PubMed ID: 11209452
    [No Abstract]   [Full Text] [Related]  

  • 15. Working hand-in-hand to manage pharmacy costs. Utah's innovative use of the Behavioral Pharmacy Management Program.
    Behav Healthc; 2006 May; 26(5):40-2. PubMed ID: 16736920
    [No Abstract]   [Full Text] [Related]  

  • 16. Omnibus Budget Reconciliation Act of 1993 (Public Law 103-66).
    Health Care Financ Rev; 1993; 15(1):177-216. PubMed ID: 10133706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug utilization review of sedative/hypnotic agents in Texas Medicaid patients. Texas Medicaid Vendor Drug Program Drug Utilization Review Board.
    Seltzer JK; Kurt TL; Knodel LC; Dean B; Burch C
    J Am Pharm Assoc (Wash); 2000; 40(4):495-9. PubMed ID: 10932458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicaid program; Drug Use Review program and electronic claims management system for outpatient drug claims--HCFA. Interim final rule with comment period.
    Fed Regist; 1992 Nov; 57(212):49397-412. PubMed ID: 10122482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a physician-focused educational intervention on medicaid children with asthma.
    Lee E; McNally DL; Zuckerman IH
    Ann Pharmacother; 2004 Jun; 38(6):961-6. PubMed ID: 15122003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detailed data reflect PMPM costs for Pennsylvania's Medicaid program.
    Capitation Rates Data; 2005 Feb; 10(2):18-22. PubMed ID: 15859497
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.